Search research articles
Contact Us
Filters
Showing results (121-130 of 304) with videos related to
Page
of 31
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Tiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Neurology
|
May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Journal of Neurology
|
July 12, 2015
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD
Franc Llorens, Niels Kruse, Matthias Schmitz, et al.
Alzheimer'S Research & Therapy
|
July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia
Davide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2008
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein
Clemens R Scherzer, Jeffrey A Grass, Zhixiang Liao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 12, 2021
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort
Nour K Majbour, Ilham Y Abdi, Mohammed Dakna, et al.
Bioanalysis
|
September 30, 2016
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
Anne-Marie Miller, Aleksandra Rutkowska, Justyna M Bahl, et al.
NPJ Parkinson'S Disease
|
May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease
Michael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 15, 2013
The role of SCARB2 as susceptibility factor in Parkinson's disease
Franziska Hopfner, Eva C Schulte, Brit Mollenhauer, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 304) with videos related to
Sort By:
Page
of 31
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 5, 2024
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice
Tiago F Outeiro, Lorraine V Kalia, Erwan Bezard, et al.
Neurology
|
May 11, 2016
Monitoring of 30 marker candidates in early Parkinson disease as progression markers
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, et al.
Journal of Neurology
|
July 12, 2015
Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD
Franc Llorens, Niels Kruse, Matthias Schmitz, et al.
Alzheimer'S Research & Therapy
|
July 29, 2017
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia
Davide Chiasserini, Leonardo Biscetti, Paolo Eusebi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease
Michael Bartl, Mohammed Dakna, Sebastian Schade, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 2, 2008
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein
Clemens R Scherzer, Jeffrey A Grass, Zhixiang Liao, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 12, 2021
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort
Nour K Majbour, Ilham Y Abdi, Mohammed Dakna, et al.
Bioanalysis
|
September 30, 2016
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
Anne-Marie Miller, Aleksandra Rutkowska, Justyna M Bahl, et al.
NPJ Parkinson'S Disease
|
May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's disease
Michael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 15, 2013
The role of SCARB2 as susceptibility factor in Parkinson's disease
Franziska Hopfner, Eva C Schulte, Brit Mollenhauer, et al.
Page
of 31